Schedule 13D ownership disclosure

Design Therapeutics Inc

Security class unavailable · CUSIP: 25056L103

Event date: 2024-08-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,217,627
Percent of class
7.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-24-000514
Form type
SC 13D/A
Filer
Design Therapeutics, Inc.
CIK
CIK 1807120
Filed
Aug 13, 2024
Reporting period
Aug 09, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub